Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms
Heather J. Chalfin(Johns Hopkins University), Kenneth J. Pienta(Johns Hopkins University), Paymaneh D. Malihi(University of Southern California), Joshua M. Lang(University of Wisconsin–Madison), Emily A. Caruso(Johns Hopkins University), Ruth F. Dumpit(Fred Hutch Cancer Center), Changxue Lu(Johns Hopkins University), Jamie M. Sperger(University of Wisconsin–Madison), C. Rory Goodwin(Duke Medical Center), Peter S. Nelson(Fred Hutch Cancer Center), Michael A. Gorin(Johns Hopkins University), Jun Luo(Johns Hopkins University), Stephanie Glavaris(Johns Hopkins University), Yan Chen(General Hospital of Central Theater Command), Peter Kühn(University of Southern California)
Cited by 27
Related Papers
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
|New England Journal of Medicine|2016|1.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
|Cancer Research|2008|1.4k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k